We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PXD
501
DELISTED
Pioneer Natural Resource Co.
PXD
$1.98M 0.02%
12,953
-23,639
-65% -$3.62M
NGM
502
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.97M 0.02%
+135,000
New +$1.98M
NTES icon
503
NetEase
NTES
$76.5B
$1.96M 0.02%
+38,400
New +$2.04M
NTLA icon
504
Intellia Therapeutics
NTLA
$1.5B
$1.96M 0.02%
120,000
– –
VTR icon
505
Ventas
VTR
$48.9B
$1.95M 0.02%
28,709
+110
+0.4% +$7.01K
VRSN icon
506
VeriSign
VRSN
$25.3B
$1.95M 0.02%
9,358
-1,381
-13% -$271K
NTR icon
507
Nutrien
NTR
$32.7B
$1.95M 0.02%
36,485
-137,862
-79% -$7.2M
ACHN
508
DELISTED
Achillion Pharmaceuticals
ACHN
$1.93M 0.02%
725,000
– –
NRCG
509
DELISTED
NRC Group Holdings Corp.
NRCG
$1.93M 0.02%
+174,159
New +$1.54M
ALLY icon
510
Ally Financial
ALLY
$13.1B
$1.91M 0.02%
62,036
-1,298
-2% -$38.3K
MPWR icon
511
Monolithic Power Systems
MPWR
$65.5B
$1.9M 0.02%
14,084
-7,014
-33% -$954K
ABEV icon
512
Ambev
ABEV
$47.3B
$1.9M 0.02%
407,700
+368,970
+953% +$1.65M
WY icon
513
Weyerhaeuser
WY
$17.3B
$1.85M 0.02%
70,522
-4,488
-6% -$114K
DLR icon
514
Digital Realty Trust
DLR
$73.7B
$1.83M 0.02%
15,602
– –
VNO icon
515
Vornado Realty Trust
VNO
$7.47B
$1.82M 0.02%
28,483
+1,978
+7% +$133K
O icon
516
Realty Income
O
$61.2B
$1.81M 0.02%
27,237
-6,575
-19% -$449K
WAT icon
517
Waters Corp
WAT
$36.8B
$1.81M 0.02%
8,430
+95
+1% +$20.8K
GHDX
518
DELISTED
Genomic Health, Inc.
GHDX
$1.78M 0.02%
30,765
+3,400
+12% +$201K
SONY icon
519
Sony
SONY
$123B
$1.78M 0.02%
170
+15
+10% +$147
DOV icon
520
Dover
DOV
$27.2B
$1.77M 0.02%
17,797
-1,154
-6% -$111K
CSGP icon
521
CoStar Group
CSGP
$11.3B
– –
-24,340
Closed -$1.24M
CNQ icon
522
Canadian Natural Resources
CNQ
$96.9B
$1.76M 0.02%
133,743
-33,160
-20% -$456K
DLTR icon
523
Dollar Tree
DLTR
$23.1B
$1.76M 0.02%
16,456
-1,056
-6% -$111K
FAST icon
524
Fastenal
FAST
$54B
$1.76M 0.02%
108,436
+876
+0.8% +$14.4K
EQH icon
525
Equitable Holdings
EQH
$13.1B
$1.75M 0.02%
84,083
+39,190
+87% +$843K
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.